Miv-cel was reported to be well tolerated in the KYSA-8 trial. No high-grade cases of cytokine release syndrome or immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback